Market revenue in 2023 | USD 2,876.1 million |
Market revenue in 2030 | USD 6,491.3 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Next generation sequencing |
Fastest growing segment | Next Generation Sequencing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Next Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays |
Key market players worldwide | Johnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 36.87% in 2023. Horizon Databook has segmented the Asia Pacific next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific region encompasses Japan and China. Emerging economies such as India and Australia also contribute towards the revenue share and growth of rest of Asia Pacific region.
Presence of a high market penetration of segments such as personalized medicine, alternative medicine, companion diagnostics, growing collaborations amongst western and eastern market participants, coupled with large population base are expected to be high impact rendering factors for the fastest growth of the regional market throughout the forecast period.
Developing healthcare infrastructure and increasing healthcare spending in the emerging economies also provides additional factors contributing towards the region’s accelerated growth through to 2024.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific next generation cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account